Stock listing
A2PA31 Stock Price, News, Filings & Events — Organogenesis Holdings Inc.
Selected listing: A2PA31 · LS · EUR · DE
This page tracks Organogenesis Holdings Inc.'s A2PA31:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PA31:LS. A2PA31:LS is the stock-level entry point for investors researching Organogenesis Holdings Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Organogenesis Holdings Inc. (ticker: ORGO) is a public company operating in the American market, with a market capitalization of approximately $307.5 million. The company specializes in regenerative medicine and advanced wound care solutions. Its innovative products aim to improve patient outcomes in various medical fields.
- Ticker
- A2PA31:LS
- Asset type
- Stock
- Market cap
- $223.9M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LS
- Currency
- EUR
Organogenesis Holdings Inc. A2PA31:LS stock context
This page tracks Organogenesis Holdings Inc.'s A2PA31:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PA31:LS. A2PA31:LS is the stock-level entry point for investors researching Organogenesis Holdings Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Organogenesis Holdings Inc. (ticker: ORGO) is a public company operating in the American market, with a market capitalization of approximately $307.5 million. The company specializes in regenerative medicine and advanced wound care solutions. Its innovative products aim to improve patient outcomes in various medical fields.
Latest news from Organogenesis Holdings Inc.
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Chall...
July 27, 2026
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
July 9, 2026
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
July 6, 2026
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
May 7, 2026
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
April 28, 2026
Organogenesis Holdings Inc. earnings calls
Organogenesis Holdings Inc. (ORGO) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Organogenesis Holdings Inc. (ORGO) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Organogenesis Holdings Inc. (ORGO) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Organogenesis Holdings Inc. (ORGO) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Organogenesis Holdings Inc. (ORGO) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Organogenesis Holdings Inc.
Organogenesis Holdings Inc. investor report
Review AI stock analysis and investor report context for A2PA31:LS.
Organogenesis Holdings Inc. company profile
View the public company page for Organogenesis Holdings Inc. on 6ix.
Organogenesis Holdings Inc. news
Read company news and market updates connected to Organogenesis Holdings Inc..
Organogenesis Holdings Inc. investor events
Find investor webinars, events, and replay context for Organogenesis Holdings Inc..
Alternate listings
ORGO:NASDAQ
US · USD
Alternate listing for Organogenesis Holdings Inc.; the primary context on this page is A2PA31:LS.
A2PA31:LSX
DE · EUR
Alternate listing for Organogenesis Holdings Inc.; the primary context on this page is A2PA31:LS.
ORGO:BOATS
US · USD
Alternate listing for Organogenesis Holdings Inc.; the primary context on this page is A2PA31:LS.
2PQ:GETTEX
DE · EUR
Alternate listing for Organogenesis Holdings Inc.; the primary context on this page is A2PA31:LS.
2PQ:TRADEGATE
DE · EUR
Alternate listing for Organogenesis Holdings Inc.; the primary context on this page is A2PA31:LS.
2PQ:DUS
DE · EUR
Alternate listing for Organogenesis Holdings Inc.; the primary context on this page is A2PA31:LS.
2PQ:FWB
DE · EUR
Alternate listing for Organogenesis Holdings Inc.; the primary context on this page is A2PA31:LS.
2PQ:MUN
DE · EUR
Alternate listing for Organogenesis Holdings Inc.; the primary context on this page is A2PA31:LS.
2PQ:SWB
DE · EUR
Alternate listing for Organogenesis Holdings Inc.; the primary context on this page is A2PA31:LS.